Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IIITerminatedD-318-2013

Drug recall · May 15, 2013

Liothyronine Sodium Tablets recall

Why: Failed Impurities/Degradation Specifications: 3 month stability testing.

Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).

The recall

Product

Liothyronine Sodium Tablets, USP, 5 mcg Rx ONLY, 100 count bottle, Distributed by: Paddock Laboratories, Inc., Minneapolis, MN 55427, NDC 0574-0220-01,

Lots / codes

12K714 exp. 12/13, 12K715 exp. 12/13

Quantity
21,667 bottles
Company
L. Perrigo Co., Allegan, MI
Distribution
Nationwide
Initiated
March 12, 2013 · Voluntary: Firm initiated
Classified
May 9, 2013
Reported
May 15, 2013
Ended
July 24, 2013
How notified
Letter

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Liothyronine

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.